Konidaris Tasos
Insider CIK 1320982 · PTX Director · KDMN Director · AMRX SVP and CFO · DCTH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-04 | 2026-03-05 | 49,982 | — | $0 | 87,963 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-04 | 2026-03-05 | 22,035 | $13.30 | $293.1K | 449,434 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-04 | 2026-03-05 | 43,982 | — | $0 | 471,469 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 458,716 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 28,538 | — | $0 | 85,617 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 57,339 | — | $0 | 57,340 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 45,290 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 458,716 | — | $0 | 657,304 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 45,290 | — | $0 | 167,442 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 229,817 | $13.31 | $3.06M | 427,487 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 14,298 | $13.31 | $190.3K | 198,588 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 28,538 | — | $0 | 212,886 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 24,251 | $13.31 | $322.8K | 184,348 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 57,339 | — | $0 | 208,599 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 16,182 | $13.31 | $215.4K | 151,260 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 72,622 | — | $0 | 72,622 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 72,622 | — | $0 | 72,622 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-15 | 2025-08-15 | 219,159 | $9.43 | $2.07M | 122,152 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-14 | 2025-08-15 | 119,206 | $9.30 | $1.11M | 341,311 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-13 | 2025-08-15 | 161,365 | $9.22 | $1.49M | 460,517 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-03-05 | 2025-03-07 | 100,000 | $8.91 | $891.0K | 621,882 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-04 | 2025-03-05 | 43,981 | — | $0 | 131,945 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-04 | 2025-03-05 | 22,497 | $8.84 | $198.9K | 721,882 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-04 | 2025-03-05 | 43,981 | — | $0 | 744,379 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 181,159 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 57,340 | — | $0 | 114,679 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 45,290 | — | $0 | 45,290 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 114,155 | — | $0 | 114,154 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 228,310 | — | $0 | 228,310 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 24,374 | $8.76 | $213.5K | 611,902 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 16,373 | $8.76 | $143.4K | 578,936 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 57,340 | — | $0 | 636,276 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 45,290 | — | $0 | 595,309 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 92,663 | $8.76 | $811.7K | 700,398 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 181,159 | — | $0 | 793,061 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-01 | 2025-03-04 | 36,197 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-01 | 2025-03-04 | 13,494 | $8.67 | $117.0K | 550,019 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-01 | 2025-03-04 | 36,197 | — | $0 | 563,513 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-12 | 2024-03-14 | 87,720 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-12 | 2024-03-14 | 87,720 | — | $0 | 558,106 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-12 | 2024-03-14 | 30,790 | $5.31 | $163.5K | 527,316 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-05 | 351,852 | — | $0 | 351,852 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-05 | 175,926 | — | $0 | 175,926 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-03 | 2024-03-05 | 57,339 | — | $0 | 172,019 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-03 | 2024-03-05 | 45,290 | — | $0 | 90,580 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-03 | 2024-03-05 | 45,290 | — | $0 | 449,070 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-03 | 2024-03-05 | 15,897 | $5.47 | $87.0K | 433,173 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-03 | 2024-03-05 | 57,339 | — | $0 | 490,512 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-03 | 2024-03-05 | 20,126 | $5.47 | $110.1K | 470,386 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-01 | 2024-03-05 | 36,197 | — | $0 | 36,197 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-01 | 2024-03-05 | 36,197 | — | $0 | 417,037 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-01 | 2024-03-05 | 13,257 | $5.47 | $72.5K | 403,780 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-03-12 | 2023-03-14 | 87,719 | — | $0 | 87,720 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-03-12 | 2023-03-14 | 87,719 | — | $0 | 380,840 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-03-03 | 2023-03-07 | 229,358 | — | $0 | 229,358 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-03-03 | 2023-03-07 | 458,716 | — | $0 | 458,716 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-03-03 | 2023-03-07 | 45,289 | — | $0 | 135,870 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-03-03 | 2023-03-07 | 45,289 | — | $0 | 293,121 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-03-01 | 2023-03-03 | 36,197 | — | $0 | 72,394 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-03-01 | 2023-03-03 | 36,197 | — | $0 | 247,832 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-03-12 | 2022-03-15 | 87,719 | — | $0 | 175,439 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-03-12 | 2022-03-15 | 87,719 | — | $0 | 211,635 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 181,159 | — | $0 | 181,159 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 362,318 | — | $0 | 362,318 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-03-01 | 2022-03-03 | 36,197 | — | $0 | 108,591 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-03-01 | 2022-03-03 | 36,197 | — | $0 | 123,916 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 116,370 | $5.92 | $688.9K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 102,040 | $5.06 | $516.3K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 100,000 | $7.21 | $721.0K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 50,000 | $6.15 | $307.5K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 50,000 | $5.38 | $269.0K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2021-05-12 | 2021-05-13 | 116,370 | — | $0 | 116,370 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-03-12 | 2021-03-15 | 87,719 | — | $0 | 263,158 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-03-12 | 2021-03-15 | 87,719 | — | $0 | 87,719 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-03-01 | 2021-03-03 | 289,576 | — | $0 | 289,576 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-03-01 | 2021-03-03 | 144,788 | — | $0 | 144,788 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2020-05-13 | 2020-05-14 | 102,040 | — | $0 | 102,040 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-03-12 | 2020-03-16 | 701,754 | — | $0 | 701,754 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-03-12 | 2020-03-16 | 350,877 | — | $0 | 350,877 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-05-15 | 2019-05-16 | 100,000 | $2.29 | $229.0K | 200,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2018-07-27 | 2018-07-30 | 50,000 | $3.35 | $167.5K | 100,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2017-06-29 | 2017-06-30 | 50,000 | $4.12 | $206.0K | 50,000 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2016-05-26 | 2016-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2015-08-14 | 2015-08-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award | 2014-07-07 | 2014-07-09 | 9,616 | — | $0 | 11,678 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2014-04-25 | 2014-04-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award | 2013-06-05 | 2013-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award deriv | 2012-07-06 | 2012-07-09 | 54,586 | — | $0 | 54,586 | SEC↗ |